0
Your cart

Your cart is empty

Browse All Departments
  • All Departments
Price
  • R1,000 - R2,500 (1)
  • R2,500 - R5,000 (1)
  • -
Status
Brand

Showing 1 - 2 of 2 matches in All Departments

Anthracycline Antibiotics in Cancer Therapy - Proceedings of the International Symposium on Anthracycline Antibiotics in Cancer... Anthracycline Antibiotics in Cancer Therapy - Proceedings of the International Symposium on Anthracycline Antibiotics in Cancer Therapy, New York, New York, 16-18 September 1981 (Paperback, Softcover reprint of the original 1st ed. 1982)
Franco M. Muggia, Charles W. Young, Stephen K. Carter
R1,651 Discovery Miles 16 510 Ships in 10 - 15 working days

F. M. MUGGIA When faced with the inadequacies of current cancer treatment, we prefer to look at what the future may hold. Quite often, we take for granted the past, preferring research into totally new areas. However, the persistent development of fertile soil may yield surprising rewards for those who choose to build on the knowledge of the past--hence, this symposium on anthracycline antibiotics. Although the anthracycline antibiotics represent much of the present and future of cancer treatment, their actual use c stretches back barely two decades to the pioneering efforts of Aurelio Di Marco, who characterized the antitumor properties of daunomycin and adriamycin. * The clinical application of these two compounds heralded a decade of excitement among oncologists dealing with pediatric tumors, breast cancer, leukemias, and lymphomas, and opened new hope for patients afflicted with sar comas and a variety of other tumors that had been deemed - sistant to chemotherapy. These successes were tempered with the realization that the antitumor effect of anthracyclines could be achieved at times only at the very high price of risking cardiac decompensation and, almost invariably, with the occurrence of alopecia and other acute toxicities. This record of past achievements and problems has slowly given way to a present increasingly illuminated by our ability to modify the distressing toxicities of these agents. Detailed clinical studies supplemented by ingenious laboratory models have gradually elucidated mechanisms and risk factors im plicated in the cardiomyopathy."

International Symposium on Adriamycin - Milan, 9th-10th September, 1971 (Paperback, Softcover reprint of the original 1st ed.... International Symposium on Adriamycin - Milan, 9th-10th September, 1971 (Paperback, Softcover reprint of the original 1st ed. 1972)
Stephen K. Carter, A Di Marco, M. Ghione, I H Krakoff, G. Mathe
R2,957 Discovery Miles 29 570 Ships in 10 - 15 working days

The impressive advances in all branches of medical science during the first half of this century with the discovery of many chemotherapeutic or immunogenic agents gave rise to brilliant achievements in the struggle against some infectious diseases and aroused in many scientists the wishful thought that drugs for cancer therapy would, soon lead to additional great success. Notwithstanding ever-increasing worldwide endeavors, the major problems in prevention or treatment of neoplastic diseases are still unsolved. The approach to the resolution of these problems follows many different pathways. Basic research tries to cast light on the genetic and biochemical processes underly ing cell division and differentiation as well as the interactions occurring between the cell and the oncogenic stimulus, or between the neoplastic cells and the different body systems endowed with immunological reactivity. Another line of approach, coherent with the classic basis of chemotherapy, relies upon the search for new compounds selectively blocking the multiplication of the neoplastic cells. The remarkable progress made in treating human cancer, as a result of these efforts, has been until now ascribable chiefly to the accomplishment of the chemo therapeutic approach. Studies on the cytostatic activity of the anthracycline antibiotics carried out over many years eventually led the investigators of Farmitalia (Milan, Italy) to discover and characterize some new compounds endowed with interesting chemotherapeutic properties against malignant neoplastic diseases."

Free Delivery
Pinterest Twitter Facebook Google+
You may like...
My Unapologetic Diaries
Joan Collins Paperback R478 R393 Discovery Miles 3 930
The Other End Of The Telescope - How To…
Ian Russell Paperback R250 R200 Discovery Miles 2 000
Archibald Constable and His Literary…
Thomas Constable Paperback R693 Discovery Miles 6 930
The Stellenbosch Mafia - Inside The…
Pieter du Toit Paperback R250 R200 Discovery Miles 2 000
Managing Business Projects - The…
Frank Einhorn Paperback R495 R468 Discovery Miles 4 680
The Dirty Secrets Of The Rich And…
James-Brent Styan Paperback R290 R205 Discovery Miles 2 050
Understanding Macroeconomics
Philip Mohr, Cecilia van Zyl, … Paperback  (6)
R425 R377 Discovery Miles 3 770
Bloedbande - 'n Donker Tuiskoms
Wilhelm Verwoerd Paperback R390 R335 Discovery Miles 3 350
The Works of Alexander Pope, Esq., in…
Alexander Pope Paperback R615 Discovery Miles 6 150
The Digital Silk Road - China's Quest To…
Jonathan E. Hillman Paperback R400 R320 Discovery Miles 3 200

 

Partners